TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.

Slides:



Advertisements
Similar presentations
Tuberculosis Control in Substance Abuse Treatment Centers
Advertisements

Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
TB/HIV Research Priorities: TB Preventive Therapy.
PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
Purpose of 2005 Guidelines Update and replace 1994 Mycobacterium tuberculosis infection control (IC) guidelines Further reduce threat to health-care workers.
Ebola Facts October 28, /28/14 Identify, Isolate, Inform: ED Evaluation and Management The following diagram provides guidance on evaluation and.
Tuberculosis in Children: Prevention Module 10C - March 2010.
HIV Exposure: What Emergency Response Agencies Need to Know About Accessing Information.
TB Contact Investigation
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
TB Outbreak in Grand Forks
Staff Health Care Infectious Disease view Jameel Adnan, MD. Community & Primary Health Care KAAU- RABEG BRANCH.
West Virginia’s Tuberculosis Control Program Hx and Epi MissionTransmissionRequirements Channels of Communication.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Division of Tuberculosis Elimination
Understanding and Preventing Tuberculosis Health, healing and hope.
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Unit 5: IPT Isoniazid TB Preventive Therapy
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Behind Bars: Correctional Contact Investigations
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
IGRAs in Practice: The San Francisco Health Department Experience Jennifer Grinsdale, MPH Program Manager/Epidemiologist Acting Director Tuberculosis Control.
MRSA in Corrections Danae Bixler, MD, MPH
Epidemiology Tools and Methods Session 2, Part 1.
Infection Control: New CDC Guidelines Kevin Fennelly, MD, MPH 2006 Northeast TB Controllers Meeting Relapse? The State of TB Control in the Era of Declining.
San Francisco Department of Public Health HIV Partner Services Update 2011 San Francisco STD Prevention and Control Services May 2011.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
Corrections Recommendations - 1 Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC 2006 Centers.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Progress of the Singapore TB Elimination Programme (STEP)
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Tuberculosis in Virginia? Wendy Heirendt, MPA Public Health Advisor Division of TB Control Virginia Department of Health September 12, 2005.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Mycobacterium Tuberculosis. Decline During ,377 cases of TB (5.8/100,000 of U.S. population) were reported to CDC 7% dec from 1999 39% dec.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
Tuberculosis (TB) in Correctional Settings: What Corrections Staff Need to Know 1.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Zero transmission TB infection CommunityHousehold Hospitals and clinics Congregate settings Early diagnosis Universal access to accurate tests Human resources.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Division of Tuberculosis Elimination Centers for Disease Control and Prevention.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
Introduction to Contact Investigation Process Amy Schmitt, BSN, RN Public Health Grand Rounds Tuberculosis November 19, 2015.
Tuberculosis in Children and Young Adults
Roundtable. Detection and treatment of TB Andrew Black.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
Depart. of Pulmonology 백승숙. More than 80% of cases of tuberculosis in the United States –The result of reactivated latent infection –Nearly all these.
Management of the Newborn When Maternal TB Suspected
Guidance on completion of Isoniazid Preventive Therapy register
This is an archived document.
Treatment of Latent TB Infection (LTBI)
This is an archived document.
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
TUBERCULOSIS IN VIRGINIA
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
بسم الله الرحمن الرحيم.
Mark Lobato, MD Division of TB Elimination
Implementing a TB-Control Program in Prisons: The Basics
Presentation transcript:

TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention Corrections Connections Forming Partnerships to Stop TB April and May 11, 2007

What’s New? (1) Broadens definition of corrections to include detention facilities Uses a risk assessment approach Recommends all inmates receive symptom screening Suggests testing by TST or QFT-Gold

What’s New? (2) Highlights importance of collaboration, education, and evaluation Emphasizes case management Expands environmental controls section and adds a section on respiratory protection Recognizes the role of ICE in screening the foreign born in the U.S.

TB Testing TST should be done within 7 days If TST positive, CXR done within 72 hours HIV-infected persons require a CXR

Facility Risk Assessment Minimum Risk Facility Zero TB cases in last year Not a “high-risk” population (HIV, IDU) Not large numbers of foreign born Employees not otherwise at risk for TB All other facilities are non-minimal risk

Individual Risk Assessment Minimum Risk Facility Inmates with TB symptoms require immediate isolation in an AII room Individuals in minimum-risk facilities require further evaluation if clinical condition or risk factor for TB HIV require CXR

Non-Minimum Risk Facility Review symptoms at entry immediately place symptomatic in a AII room TB test (TST, QFT-G, CXR) within 7 days CXR for HIV infected or immunosuppressed Consider therapy for positive test results

TB Screening: > Minimal Risk Facility Entry Screen for symptoms TB Symptoms Present? Obtain medical History Yes No Isolate and evaluate If treatment not completed, CXR and evaluate Previous TST + documented? Yes

TB Screening: > Minimal Risk Facility Retest periodically In long-term facilities Yes No CXR and evaluate HIV+ or at risk for HIV but status unknown? No previous TST+ documented TST* or QFT-G TST+ or QFT-G? Yes CXR and evaluate *2-step testing recommended for Initial testing in facilities that perform periodic TST testing

Recommendations Report suspect cases by all entities including federal facilities to local or state HD Screen all incoming inmates at entry with at least a TB symptom review Perform risk assessment Isolate TB suspects immediately Plan for discharge early Provides a special section on ICE detainees

New and Renewed Emphasis Summarizes treatment for TB and latent TB infection Expands on collaboration between health departments and medical staff Emphasizes contact investigations Provides details for evaluation of TB control activities Offers guidance on training and education

Airborne Infection Isolation (AII) Initiate TB AII precautions for any patient who Has signs and symptoms of TB disease Has not completed treatment Has not previously been determined non- infectious

When to Discontinue AII Discontinue AII when infectious TB is unlikely Another diagnosis is made Patient has 3 negative AFB sputum smears If patient has 3 negative AFB smear results Release after starting 4 anti-TB drugs Patient improving clinically

LTBI - Treatment Prioritize patients Preferred treatment 9 months INH Daily or biweekly (DOT) Other regimens 4 months rifampin NOT 2 months of pyrazidamide and rifampin Drug resistance

Collaboration Requires formal mechanisms Designated liaisons Regular meetings Written agreements Case management Discharge planning Contact investigations

Case Management Care should be individualized Management should be coordinated with health department Most inmates released before treatment is completed Evaluate outcomes

Detention Center- Jail Hospital Clinic Shelter Homeless Clinic Soup Kitchen Jails – A Community Institution

Discharge Planning Requires coordination between corrections and public health Begin as soon as possible Interview by health department should occur before release

Contact Investigations Goal is to interrupt TB transmission Collaboration with public health essential Scope of investigation depends on Site of TB disease (pulmonary, laryngeal) AFB smear status (smear positive) “Index of suspicion”